Research Team
![](https://mandayahospitalgroup.com/wp-content/uploads/2023/07/regenerativ-300x70.png)
![](https://mandayahospitalgroup.com/wp-content/uploads/2024/04/dr-mulawarman.jpg)
Dr. dr. Achmad Mulawarman Jayusman, Sp.P(K)
Doctor in Pulmonology from Gadjah Mada University, Yogyakarta
Pulmonologist and Consultan of Lung Cancer & Interventional Pulmonology
Mandaya Royal Hospital Puri
Scopus Profile: https://www.scopus.com/authid/detail.uri?authorId=6505493535
Publication:
- Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
- Clinical characteristic of thoracic malignancy patients with coronavirus disease 2019 related to mitigation strategy in dharmais national cancer center hospital, Indonesia
- Correlation of serum electrolytes with serial miRNA in advanced stage non-small cell lung cancer (NSCLC) in Indonesia
- Preparing For The Next Pandemic: An Asian National Cancer Centers Alliance (Ancca) Initiative
- Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19
- Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as mortality predictor of advanced stage non-small cell lung cancer (NSCLC) with COVID-19 in Indonesia
- Serum MiRNA as predictive and prognosis biomarker in advanced stage non-small cell lung cancer in Indonesia
- Analysis of Acrylamide in Dried Blood Spots of Lung Cancer Patients by Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry
- A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit
- Experience of treatment of lung cancer patients using paclitaxel and carboplatin